It may sound like science fiction, but viruses aren’t just enemies. They can also be powerful allies. For many years, we’ve been taught to fear viruses, especially the fact that we’ve lived through several virus outbreaks, like Ebola and coronavirus, to name a few. They are often seen as the invisible invaders that endanger our health and well-being and are the source of deadly illnesses.
But here is a shocker: these microscopic agents, which have long been our adversaries, are now being harnessed for good. Instead of harming the body, these viruses help fight against cancer, one of the world’s most lethal illnesses. This novel concept lies at the core of a fresh approach known as oncolytic virotherapy, which uses viruses that have been specially engineered to target and kill cancer cells.
Challenges of Oncolytic Virotherapy
Immune Response to the Virus: A big challenge in using viruses to treat cancer is that our immune system naturally tries to attack any virus it finds. The body’s defense system sees the virus as a threat, so it tries to get rid of it before it can even do its job, which is destroying the cancerous cells.
While this response is normally helpful in protecting us from infections, it can make treatment less effective because the virus may be destroyed before it can attack the tumor. However, scientists are now making research on ways to manage this immune response. Without weakening the immune system, they hope to shield the virus long enough for it to get to the tumor and begin its activity.
Tumor Heterogeneity: Another big challenge is that tumors are not made of identical cells. Tumors often have a mix of different cancer cell types, each with its own traits and behavior. The virus can kill some cells, but others may survive and grow. That is why researchers are seeking to create viruses that can infect many types of cancer cells or to combine the virus with other treatments to help remove more resistant cancer cells.
Delivery and Distribution of the Cells of the Viruses
Getting the virus to reach and spread throughout the entire tumor can be really difficult. Tumors can be large or deep inside the body, making it hard for the virus to get to every part. Even if the doctor injects the virus directly into the tumor, it might only infect cells close to the injection site, ignoring cells farther away. In order for the virus to infect each part of the tumor, researchers have to find better methods of delivering it.
Summary
Oncolytic virotherapy is a novel cancer treatment that targets and destroys cancer cells using viruses. Although it has a lot of potential, there are several major challenges. First, before the virus reaches the cancer cells, our immune system typically destroys it. Second, tumors have many different types of cancer cells, and some are harder to attack than others. Third, it’s tough to spread the virus throughout large or deep tumors. Scientists are working hard to solve these problems so that this treatment can become safer and more effective in fighting cancer.
